|
1. INTRODUCTION
Cannon was the first to recognize that higher organisms exert a
neuroendocrine reaction when in pain or when faced with danger, which is
know as the “fight or flight” response [226]. Hans Selye discovered
that a variety of noxious agents cause a profound involution of the
thymus, spleen and lymph nodes, and the enlargement of the adrenal gland.
Selye showed that these changes were mediated by the activation of
the pituitary-adrenal axis and that glucocorticoids were responsible for
the lymphoid involution observed [1]. Physical, chemical, biological
agents or even emotional factors could evoke this neuroendocrine response,
which were designated by Selye as stressors and their effect was defined as
stress. He termed the body's reaction to stress as the general
adaptation syndrome. Stressed animals and individuals show an initial alarm
reaction, which is followed by a period of resistance or adaptation.
Adapted animals show resistance towards the stressor and to various other
insults in general. Eventually, with lasting stress, a breakdown due to exhaustion
may occur, which can lead to death [2,3].Selye [4] also discovered the inhibitory effects of glucocorticoids
on inflammation and made observations indicating that immune reactions are
also subject to stress- induced alterations [5]. He demonstrated the influence of sex steroid hormones on lymphoid
organs [6].
2.THE RESPONSE TO
INJURY
It is now apparent that the general adaptation syndrome of Selye is
analogous to the intensive and highly co-ordinated emergency defence
reaction in man and in higher animals, which frequently manifests in febrile
illness, and is now designated as the acute
phase response (APR)[7-11,12]. In a broad sense the
agents capable of causing injury and consequently APR may be classified
into physical, chemical and biological categories. Without exception injured cells release chemokines and cytokines,
which in turn attract and activate leukocytes that secrete cytokines. The
cytokines in turn elicit a neuroendocrine and metabolic response
characteristic of APR. Amongst the physical agents studied in this respect
are ultraviolet irradiation of the skin, X-irradiation, cold and burn
injury, and major surgical operations. In severe cases injuries lead to
APR [11, 13-15]. Chemical agents causing toxic injury exert similar
effects [16]. Biological injury caused by infectious agents, toxins, or by
immune effector mechanisms.Substances
that are otherwise harmless to the body may also cause severe injury if
there is an abnormal immune response (hypersensitivity) directed against
them. Tissue injury may be mediated by IgE antibodies (immediate hypersensitivity, allergy, asthma,
anaphylaxis), by sensitized T lymphocytes (delayed hypersensitivity,
contact dermatitis, cytotoxicity), by immune complexes and by phagocytic
cells activated either by antibodies or cytokines. Humoral or cell mediated immune reactions may also be directed
against self-antigens that could lead to autoimmune disease [11,17,18-23].
3. THE ACUTE PHASE RESPONSE
Wannemacher et al [24] isolated a protein from leukocytes and named
it leukocytic endogenous mediator (LEM), which stimulated the uptake of
amino acids by the liver in adrenalectomized (ADX), hypophysectomized (Hypox),
thyroidectomized or diabetic rats. Similar stimulation could not be duplicated by pharmacological doses of a large
variety of hormones. LEM augmented RNA synthesis and enhanced the hepatic
production of a number of acute phase plasma globulins. Because the best
known experimental model of APR is the syndrome elicited by bacterial
endotoxin, we discuss first the characteristics of this reaction.
3.1 The response to bacterial
endotoxin.
Lipopolysaccharide (LPS), also known as endotoxin,
is a constant component of the outer cell membrane of Gram-negative
bacteria. Biochemically it
can be divided into polysaccharide and lipid regions. The core glycolipid,
lipid A, plus the core polysaccharide, are obligatory components of the bacterial cell wall, as mutants lacking
this component are not viable. In contrast, there is great variation of the polysaccharide chain sugars,
which differ from one bacterial strain to the other and provide epitopes
for adaptive immune reactions and for the serological classification of
Gram-negative bacteria [25]. The capsular polysaccharides, which are present in bacteria forming
"smooth" colonies and provide the so-called K antigens, and the
O-specific polysaccharides of LPS, contain heterologous
epitopes. These are recognized specifically by the adaptive immune
system, according to the individual bacterial strains.On the other hand, lipid A is evolutionarily highly conserved and
shows extensive cross-reactivity amongst all Gram-negative bacterial
strains, whether they are pathogenic or saprophyte. This antigenic determinant may be classified as a homologous epitope, or homotope
for short. Lipid A is recognized by both the natural and the adaptive
immune system. It is possible to produce anti-lipid A antibodies, including monoclonal antibodies, with
deliberate immunization [7, 25].
It has long been established that lipid A is the "toxic
moiety" of endotoxin, which is capable of a massive activation of the
immune system, and in turn, and immune derived cytokines may induce shock
and death [12]. Lipopolysaccharide binding protein (LBP) is present in the
serum, which is produced by the liver. LBP has been identified in the serum of multiple species, including
rabbits, rats, mice, pigs, cattle, non-human primates, and humans. LBP combines with lipid A after Gram-negative infection or
LPS injection [26]. LBP is a 60 kDa glycoprotein present in normal serum at concentrations of 0.5-10 µg/ml
and its level may surpass 200 µg/ml during APR [27].Its specificity is directed towards the hydrophobic lipid A portion
of LPS with an affinity of 10-9 M for both smooth and rough
forms of LPS [28].LBP acts
as an opsonin for LPS bearing particles by enhancing its interaction with
the CD14 cell surface molecule, which is present on the surface of
monocytes, macrophages and neutrophilic granulocytes. LBP serves as a lipid transfer protein that facilitates the rate of
transfer of LPS to CD14. This enables the cell to respond to extremely low levels of LPS, which
otherwise are unable to elicit a biological response [29]. Another serum protein, which mediates LPS recognition by CD14 is
septerin [30].
CD14 is a 55 kDa glycoprotein present on the surface of monocytes,
macrophages and neutrophils. It lacks a transmembrane sequence [31]. CD14 plays an important role in mediating the induction of
cytokines by LPS, such as tumor necrosis factor-α (TNFα), IL-6
and IL-8, in monocytes and macrophages. 1-25-Dehydroxyvitamin D3 (VD3)
induced CD14 expression in a premonocytic cell line.
IL-4 decreased CD14 expression, and IL-4 or interferon-γ (IFN-γ)
inhibited soluble CD14 release by monocytes. TNFα and LPS enhanced
CD14 expression by monocyte cell lines. In human neutrophils, TNFα,
granulocyte-macrophage colony stimulating factor (GM-CSF), G-CSF and
formyl peptide have all increased CD14 expression. In addition to
mediating the LPS response, CD14 appears to participate in diverse
cellular responses that involve cell-to-cell contact [32].
The serum
concentration of CD14 in normal human plasma is 6 µg/ml and increases in
hospitalized patients, especially in those suffering from autoimmune
disease. LPS and TNF increase the release of CD14, whereas IL-4 decreases its release in vitro from normal peripheral blood
monocytes.
Soluble CD14 inhibits the biological activities of LPS and is
assumed to present LPS to endothelial cells [32]. Toll-like receptor 4 is required for signal transduction by
complexes of LPS and membrane bound CD14, which leads to nuclear factor (NF)kappaB
activation [33]. Serum CD14 is an acute phase protein and its production is stimulated by IL-6 in the liver. [34 ].
The sensitivity to LPS toxicity differs considerably among various
species of mammals. Lower vertebrates, such as frog and fish, show extreme resistance [35]. Nevertheless some observations suggest that at least some
species of fish (Tilapia oreochnomis mossanbicus, Teleosti) react to LPS
and shows an integumental and a cortisol response [36]. In contrast, the horseshoe crab (Limulus polyphemus) responds to
LPS with fatal intravascular coagulation. This is due to the activation by endotoxin of a clottable protein
of Limulus blood, which is produced by circulating amoebacytes [37-39].
It seems apparent that lipid A has no inherent toxicity, but
rather, it is a highly conserved homologous
epitope, which has been singled out during evolution by vertebrate and
some invertebrate animals for defence purposes against Gram-negative
bacterial infections [7,35,40]. Lipid-A, which is the specific homotope
involved, is recognized by serum proteins and cell surface receptors,
which are capable of activating the coagulation and complement systems and
various members of the leukocyte series. This enables the animal to mount a rapid and effective immune
defence reaction against all Gram-negative pathogens [7-12].
In the mouse approximately 7% of genes are mobilized during hepatic
APR response to LPS. The extensive metabolic adjustments include
suppression of pathways for cholesterol, fatty acid, and phospholipid
synthesis. Increased expression of genes for innate defense was
accompanied by coordinate induction of the major histocompatibility
complex (MHC) class I antigen presentation machinery, illustrating an
intersection between innate and adaptive immunity [41].
3.1.1 Cytokine response to endotoxin.
After systemic administration of LPS to mice, TNFα is
significantly increased in the blood at 1-2 hours, which is followed by a
decline, the TNF level returning to normal at around 4 hours. In ADX animals an exaggerated TNF response occurs, whereby TNF
levels in the plasma rise approximately 60 times higher, and sensitivity
to the lethal effects of TNF increases approximately 500 times over that
is observed in normal control animals after LPS injection. This excessive response and increased mortality can be prevented if
the animals are pre-treated with dexamethasone.
The inhibition of cortisone synthesis in the adrenals by metyrapone
also leads to an increased susceptibility (~15 times) to LPS [40-42].
Similar kinetics of TNF release was found in man after LPS infusion
[44].
Interleukin-1 also rises in the blood of mice after endotoxin
administration reaching the maximum at about 4 hours and elevated levels
remain up to 24 hrs [43, 34]. Circulating IL-6 increases significantly after LPS administration. In man IL-6 peaked at 120 minutes after LPS administration, which
was not inhibited by glucocorticoids or by repeated LPS administration
[11, 45,46].
Leukemia inhibitory factor (LIF) rose moderately in mice after a
sub-lethal injection of LPS and rose progressively during lethal septic
shock induced by E-coli. LIF administration to mice induced catabolism and had a protective effect if
given prior to the administration of bacteria [47].
Additional cytokines and mediators also play a role in endotoxin
shock that include interleukin-8 [48], interleukin-10 [49], interferon-γ
[50], TNF synthesis inhibitor [51], interleukin receptor antagonist [52],
platelet activating factor, colony stimulating factor, prostaglandins and
thromboxanes [11,12,53].
3.1.2 Neuroendocrine response to endotoxin.
Wexler et al [54] observed for the first time the stimulation of
adrenocorticotropic hormone (ACTH) in rats by endotoxin as detected by the
depletion of ascorbic acid and cholesterol in the adrenal glands. LPS was ineffective in causing these changes in the adrenal glands
of hypophysectomized rats.
Endotoxin, infectious disease, and various forms of injury all
elicit a neuroendocrine response via the stimulation of cytokines [11,12]. Profound
changes occur in serum hormone levels. It is clear that dynamic and
diurnal changes of hormones should be taken into consideration. Much remains to be elucidated about the significance of these
hormonal alterations. Nevertheless, it is certain that the hypothalamus-pituitary-adrenal (HPA) axis exerts a
powerful suppressive effect on the adaptive immune system and controls the
level of inflammatory cytokines. Through the activation of this axis,
specific immune reactions are profoundly suppressed, whereas the induction
of acute phase proteins in the liver and natural antibody production are
augmented by glucocorticoids and catecholamines, which are also elevated.
Therefore, the conversion of the immune system from the adaptive mode of
reactivity to the amplification of natural immunity is largely due to the
activation of the HPA axis and of the sympathetic nervous system, e.g. sympathetic
outflow [12,54-57]. Prolactin and growth hormone stimulate the adaptive immune system and usually rise
within the first hour after endotoxin injection, which is followed by a
decline and the level may become low normal to subnormal in serious cases
of endotoxin shock. Luteinizing hormone (LH), follicle stimulating hormone (FSH), estrogens, androgens,
progesterone, and thyroid hormones all decline during infection and
endotoxin shock, as a rule. Insulin,glucagon, α-melanocyte stimulating hormone (MSH), endorphin, leptin,
corticotropin releasing hormone (CRH) and arginine vasopressin are
increased during endotoxemia [11,12,40,58-62] (Table 1, Figure1)
|

|
|
Legend:
Figure 1. Immunoconversion during the acute phase response.
The
acute phase response (APR) is a systemic inflammatory reaction.
Fever is a hallmark of the APR, of febrile illness. Immune
–derived cytokines, primarily IL-1, IL-6 and TNF-alpha, are
released by the immune system and act either on nerve terminals or
on the brain. The cytokine signals eventually are registered in the
hypothalamus and a powerful neuroendocrine and metabolic response to
the infection/injury is initiated. From the hypothalamus
corticotrpoin releasing hormone (CRH) and vasopressin (VP) are
secreted during APR. Both of these peptides stimulate the
hypothalamus-pituitay-adrenal axis (HPA). In addition VP has the
capacity to stimulate prolactin (PRL) secretion. Initially CRH
prevails and the activation of the HPA axis is dominant. This is
coupled with “sympathetic outflow” from the adrenal gland. The
increased level of glucocorticoids (GC) and cathecolamines (CAT),
together with TNF alpha are of prime importance of inducing thymus
involution (e.g. by inducing apoptosis of CD8+4+ thymocytes) and of
inhibiting the T cell dependent adaptive immune system. Other factors that are likely to contribute to this
suppression are the down-regulation of growth hormone and prolactin
synthesis and zinc deficiency.
During
APR the synthesis of acute phase proteins (APP) is amplified in the
liver by IL-6, GC and CAT. Serum C-reactive protein (CRP) will go up
as much as 1000 times of the basal level within 24-48 hrs. CRP is capable of recognizing pathogenic organisms and to
activate complement and leukocytes for phagocytosis and cytotoxicity.
Other serum proteins with similar biology are lipopolysaccharide-binding
protein (LBP) and mannan binging protein (MBP). Additional acute phase
proteins (APP) are fibrinogen and a number of anti-inflammatory and
enzyme inhibitory proteins, that also rise in the serum during APR.
Natural antibodies, that are poly-specific similarly to CRP LBP and
MBP, are also stimulated during APR and serve to identify pathogenic
agents, which is followed by immune activation. Therefore the
essence of febrile illness is to switch over the immune system from
the adaptive (T cell dependent) mode of reactivity to the activation
of innate/natural immune mechanisms. This process is coined as immunoconversion.
During the chronic phase of inflammmatory disease CRH will subside and VP
will take over the regulation of the HPA axis. Because VP also
stimulates PRL secretion, it is hypothesized that VP alters the
neuroendocrine milieu to favor the restoration of adaptive
immunocompetence. This process is named immunoreversion, which will lead to recovery from acute illness.
|
| Table
1. Major neuroendocrine changes induced by endotoxins |
|
| HPT and GLH Hormones |
Response |
The HPA Axis |
Response |
Gonatatropin & Sex Hormones |
Response |
|
|
|
PRL receptor (PRLR) mRNA and protein levels were down-regulated in
hepatic tissues after i.p. LPS injection. A suppressive effect on mRNA
expression was also observed in prostate, seminal vesicle, kidney, heart,
and lung tissues. PRLR mRNA levels were increased in the thymus, and did
not change in the spleen. The proportion of transcripts for the different
receptor isoforms (long, S1, S2, and S3) in liver and thymus was not
altered by LPS injection [63].
Peripherally administered LPS induces anorexia, which is prevalent
in females. Estradiol is capable of inducing this response. Estradiol
affects meal frequency [64]. Hepatic dehydroepiandrosterone (DHEA)
sulfotransferase (Sult2A1) activity and serum levels of DHEA-sulfate were
significantly decreased in LPS-treated animals. TNF and IL-1 caused a
significant decrease in the mRNA level of Sult2A1 in Hep3B human hepatoma
cells [65]
3.1.3 Endotoxin shock.
Geller et al [66] observed that the administration of the
glucocorticoid (GC), cortisone, to mice prior to, or simultaneously with,
a lethal dose of LPS protected the majority of the animals from death, but
there was no protection when cortisone was administered after LPS
injection. The protective effect of GC against endotoxin shock has been
since observed repeatedly in various species [67,68].
No correlation was found between TNF serum levels and the lethal
effects induced by different types of LPS in rats [69]. The co-treatment of rats with low doses of TNF and LPS resulted in
the rapid demise of the animals leading to 100% mortality within 4 hours
[70].Pre-treatment of rats with a single low i.v. dose of TNF prevented subsequent death from a
lethal dose of TNF or of LPS applied 24 hours later [71]. The lethal
effect of endotoxin could be inhibited in various animal models by the
opioid antagonist, naloxone, by indomethacin, by monoclonal antibodies to
TNFα and by the pharmacological inhibition of platelet activating
factor (PAF) [11]. Anti-inflammatory cytokines, such as the IL-1
receptor antagonist [71], the TNF synthesis inhibitor [72], IL-10 [73],
leukemia inhibitory factor [74], all participate in the down regulation of
the noxious effects of endotoxin. Interferon-γ
antagonizes the development of endotoxin tolerance [75].
In vitro observations revealed that the direct exposure of
macrophages to LPS also leads to decreased activation and cytokine
production upon re-exposure to LPS [76,77].
Previte et al [78] discovered that the exposure of endotoxin to
ionizing radiation resulted in significant loss of toxicity. Subsequently Bertok and coworkers [79] demonstrated over a number
of years that radiodetoxified endotoxin is capable of boosting host
resistance against infectious agents, radiation, septic shock, tourniquet
shock, intestinal ischemic shock, hemorrhagic shock, X-irradiation and
even against immunosuppression by anti-lymphocytic serum [80, 81]. Radiodetoxified endotoxin has been tested clinically for the
treatment of infectious disease in man [81]. Monophosphoryl lipid A preparations of low toxicity are also
studied in animals and man for boosting host resistance to infections and
traumatic events [82,83].
3.2 The Pathomechanisms of APR.
Clinically, APR is characterized by fever, loss of appetite,
inactivity and sleepiness. Changes in sleep are hallmarks of
the acute phase response to infectious challenge. The regulation of these
responses involves a cytokine cascade within brain, including IL-1 and TNF,
and several other substances such as growth hormone releasing hormone, PRL,
nitric oxide and NFkappaB. These substances are also involved in the
regulation of normal spontaneous sleep.
3.2.1 Cytokines and hormones
Acute febrile illness (e.g. APR) is mediated by cytokines, GC and
cathecolamines. Cytokines appear in the circulation and function as acute
phase hormones affecting the central nervous system (CNS), the
neuroendocrine system and virtually the function of every other tissue and
organ in the body. IL-1, IL-6 and TNFα have been identified as major
mediators of the endocrine and metabolic changes characteristic of APR. However, several other cytokines have been found to be inducers of
acute phase proteins (APP) [7, 9-12,85]. ACTH and GC, leptin (LEP), epinephrin (EP), norepineprin (NEP),
glucagon (GLN), vasopressin (VP), and aldosterone (ALD) are elevated
during the APR, whereas GH, PRL, estrogens, androgens, insulin (IN), and
thyroid hormones may be either elevated or suppressed, depending on the
severity of the condition [7-12,85, 86].
A subset of marrow-derived
brain macrophages, termed perivascular
cells, synthesize prostanoids after systemic cytokine or endotoxin
challenges. These brain macrophages are critically involved in the
interleukin-1-induced hypothalamo-pituitary-adrenal axis activation. This
suggests a two-way interaction between perivascular and endothelial cells
in monitoring circulating cytokine signals [87].
In most burn patients bone density dropped significantly 6 and 12
months post-injury indicating bone resorption. Cortisol was elevated, both
in blood and in urine (free cortisol). There was very low testosterone,
dihydrotestosterone (DHT) and free testosterone levels in blood of males,
but not of females. 17beta-estradiol was elevated in many burned males;
but was generally normal in burned females. DHEA-S levels were generally
low. Triiodothyronine (T3) and of the free thyroxine (FT4) was vey low.
Increased, even very high, PTH values were occasionally present. hGH and
IGF-1 were generally normal. Total and ionized calcium levels were low
after burn, 25-0H vitamin D was usually low or low normal. Osteocalcin
levels were initially low to low normal, to increase later to the normal
levels. In most instances elevated levels of TNFalpha, IL-2, IL-6 and IL-8
levels were found. The use of anabolics, of vitamin D, of calcium, and
eventually of calcitonin was suggested for treatment [88].
During APR (eg. sepsis) the serum
level of leptin rises rapidly. Cytokines, especially TNFα, causes
this elevation. LEP inhibits glucocorticoid and IL-6 production. The
levels of LEP in serum correlate positively with the survival of patients
with septicaemia. LEP stimulates the production of IL-1 receptor
antagonist, which protects against LPS toxicity in mice. LEP stimulated
the production of IL-1β in murine glial cells. Exogenous LEP
upregulated both phagocytosis and the production of proinflammatory
cytokines in animals. Leptin is also involved in wound healing and
angiogenesis [89-98]. Chronic leptin deficiency in ob/ob mice interfered with adequate control of zymosan-induced
arthritis [98].
3.2.2 Acute phase proteins
An
alteration of protein synthesis by the liver is most characteristic for
APR.The synthesis of acute phase proteins (APP) is initiated, whereas the synthesis of some normal
serum constituents such as albumin and transferrin is decreased.
The concentration of APP increase dramatically in the serum.
For example, in man, C reactive protein (CRP) and serum amyloid A (SAA)
may increase over 1,000-fold within 24-48 hours. Fibrinogen, "1-antitrypsin and certain complement and
properdin components (factor B and C3) show a more moderate increase [7,
12]. In man IL-6 exerted a hyperglycemic effect, whereas IL-2 induced a decrease in blood glucose
concentration [100].
CRP binds to C-type pneumococcal cell walls in the presence of Ca2+.
CRP has been identified in multiple species, including mammals,
chicken, fish and crab. In the serum CRP consists of 5 identical subunits, which form a ring-shaped
molecule named pentraxin. This term now also stands for a protein family.
In man, serum amyloid P also belongs to this family.The mature subunits consist of 206 amino acids with 23 kDa
molecular weight [101].
CRP recognizes specifically several homotopes, such as
phosphocholine, with polysaccharides containing galactose, with some
biologic polycations, such as protamine, poly-L-lysin
and with myelin basic protein. CRP is in its pentameric form, if Ca2+ is present, and binds
phosphocholine and galactans, whereas in the absence of Ca2+,
it becomes monomeric and binds various polycations. These homotope determinants are frequently present on the surface
of bacteria, fungi, parasites and damaged cells and tissues. After combination with the specific ligand, CRP activates
complement by the classical pathway, induces chemotaxis and enhances
phagocytosis by neutrophilic leukocytes and monocytes and elicits
tumoricidal activity in macrophages, all of which are complement
dependent. In addition, CRP stimulates the synthesis of IL-1, TNF", and potentiates the
cytotoxic activity of T lymphocytes, natural killer (NK) cells and
platelets. CRP localizes in vivo at sites of inflammation. It
binds platelet activating factor (PAF) and blocks its activity. The clinical determination of CRP is diagnostic for the presence of
infectious and inflammatory disease [101-104].
CRP influence PMN adhesion, migration and expression of CD11b/CD18
and fibronectin receptors, and can modulate the action of IL-8 on
polymorphonuclear cell (PMN) attachment to endothelium and fibronectin,
and on PMN traffic through the extracellular matrix during
transendothelial migration [105].
Upon denaturation or after attachment onto polystyrol plates, free
CRP subunits attain a third conformation referred to as neoCRP.
NeoCRP is a membrane protein on NK cells and macrophages and
functions as galactose-specific receptor.It also accumulates at injured sites of tissue.
Monocyte/macrophages express a specific CRP receptor.Proteolytic fragments of CRP activate macrophages and neutrophils
[101]. Human CRP protected mice from an otherwise lethal S. pneumoniae infection [104].
The LBP shows a 100-fold increase (from 0.5-50 µg/ml) in the serum
during an APR. LBP is capable of opsonizing LPS bearing particles, and thus
may be required for the activation of complement by endotoxin through the
alternate pathway.LBP-LPS complexes are also potent stimulators of cytokines from monocytes and
macrophages after combining with CD14 on the surface of these cells [26].
In man high-dose LBP (hd-LBP) suppressed the binding of both R-type
and S-type LPS to CD14 and inhibited LPS-induced nuclear translocation of
NF-kappaB. This inhibitory effect of serum could be mimicked by purified
high-density lipoprotein (HDL) in serum-free medium, indicating an LBP-mediated
transfer of preferentially S-type LPS to plasma lipoproteins such as HDL
[106].
Haptoglobin
is an acute phase protein. It binds haemoglobin, thus preventing iron loss
and renal damage. Haptoglobin is an antioxidant, has antibacterial activity and plays a role in
modulating many aspects of the acute phase response [107]. Haptoglobin selectively antagonized LPS
effects in vitro by suppressing monocyte production of TNF-alpha, IL-10
and IL-12, but failed to inhibit the production of IL-6, IL-8 and IL-1
receptor antagonist. Haptoglobin knockout mice were more sensitive to LPS
effects then were their wild-type counterparts [108].
The acute phase proteins alpha(1)-acid glycoprotein and
alpha(1)-antitrypsin exert antiapoptotic and anti-inflammatory effects and
contribute to the delayed type of protection associated with ischemic
preconditioning in the kidney and in other insults [109].
Mannose-binding lectin (MBL) is a serum protein characterized by both
collagenous regions and lectin domains, which plays an important role in
innate immune defence. It binds to the repeating sugar arrays on many microbial surfaces through
multiple lectin domains. Following binding, MBL is able to activate the complement system via an associated
serum protease, MASP-2. There is an increased incidence of infections in individuals with mutations of
MBL and an association with the autoimmune disorders SLE and rheumatoid
arthritis [110]. MBL activates the complement cascade and inflammation following binding to
carbohydrate structures. The serum concentration of MBL is subject to
large individual differences. Growth hormone influences MBL levels [111]. Mouse MBL-A and MBL-C were studied in various strains and in APR.
The MBL-A and MBL-C levels in 10 laboratory mice strains were found
to vary between 4 µg/ml to 12 µg/ml, and 16 µg/ml to 118 µg/ml,
respectively. After the induction of APR by the i.p. injection of casein or LPS, MBL-A was found
to increase approximately two-fold, with a maximum after 32 h, while MBL-C
did not increase significantly. Serum amyloid A peaked at 15 h with an
approximate 100-fold increase [112].
Other APP are proteinase
inhibitors, such as "2-macroglobulin, "1-acid glycoprotein,
antithrombin III, "1-acute phase globulin, and "1-proteinase inhibitor, which are abundant in
the rat. Kupffer cells stimulate "2-macroglobulin synthesis by hepatocytes in
vitro in the presence of 10-9 M DEX. Fibrinogen
is also and APP with an important role in blood clotting and healing. Alpha-macrofetoprotein ("-MFP) is a strong inhibitor of inflammatory
mediators, such as histamine, bradykinin, serotonin, PGE2 and inhibit
polymorphonuclear chemotaxis [113].
3.2.2.1 Regulation of
APP production.
Catecholamines and GC induce "-macrofetoprotein
(MFP) in normal rats. The "-MFP level induced by cathecolamines (CAT) was very high, comparable to
those observed in the post-injury phase, whereas the effect of GC was
moderate. In ADX rats the effect of CAT on "-MFP synthesis was greatly diminished, whereas
the moderate effect of GC remained. The
combination of GC and CAT induced extremely high "-MFP levels in ADX animals.
Some other APP, such as haptoglobin and "1-major acute phase protein,
were affected differently by these hormones [114].
Glucocorticoids (GC) exert a stimulatory effect on a variety of
inflammatory response components. This is usually observed at near basal
GC concentrations. For example, such stimulation was observcrd for the
hepatic APR, for cytokine secretion, expression of cytokine/chemokine
receptors, and for the pro-inflammatory mediator, macrophage migration
inhibition factor [115].
IL-1 and TNF induced a full range of APP in
vivo, but only a limited number of APP were induced by these cytokines
in cultured liver cells compared with crude cytokine preparations from
macrophages. This led to the
discovery of IL-6 as a major inducer of APP synthesis. Additional cytokines, namely IFN-(, leukemia inhibitory factor, TGF-$, and oncostatin M, were
found to be active as direct inducers of APP from the liver. IL-6 activates the genes of APP through the DNA binding protein
called NF-IL-6. NF-IL-6 is a pleiotropic mediator of many inducible genes involved in the acute-,
immune- and inflammatory responses, similarly to NF6B. Both NF-IL-6 and NF6B binding sites are present in the inducible
genes, such as IL-6, IL-8 and several acute phase genes [116].
Adrenalin evokes a high level of IL-6 in rats, which can be
antagonized by propranolol. When IL-6 release is blocked, the fast reacting APP,
2-macroglobulin and cysteine protease inhibitor are strongly depressed.
Isoprenalin, a 2-adrenergic receptor
agonist, also causes very high levels of IL-6, indicating that 2 receptors are involved
[117].
During chronic liver injury induced by biweekly application of CCl4,
deletion of the gp130 receptor in nonparenchymal
liver cells and not hepatocytes resulted in fibrosis progression. This
indicates the involvement of IL-6 in the pathogenesis of liver diseases
and suggests a protective role of IL-6/gp130-dependent pathways in
nonparenchymal liver cells during fibrosis progression in chronic liver
diseases [118].
The
relationship between spontaneously occurring activation of the acute phase
response and leptin levels were examined in 29 chronic hemodialysis
patients. When CRP was elevated, leptin levels were significantly reduced,
as were the negative acute phase proteins albumin and transferrin. Serum
amyloid A, ceruloplasmin, alpha-1 acid glycoprotein, and IL-6 were all
significantly increased at the maximum CRP level, compatible with general
activation of the acute phase response. The change in leptin correlated
negatively with the change in CRP, as did changes in albumin [119].Pro-inflammatory cytokines, especially TNF, induce inflammatory hyper-leptinemia. This is an
integral part of APR and necessary for comprehensive immunocompetence.
This indicates the existence of an integrated communication network
to co-ordinate the energy status of the animal with the ability to fight
pathogens [120].
The thymus is severely affected by stress and APR, which rapidly
leads to the loss of thymocytes manifesting in profound involution. The thymus is a central primary lymphoid organ responsible for the
generation of mature, functional thymus-derived (T) lymphocytes. In turn T lymphocytes govern adaptive immune reactions through
their regulatory function. In addition, the thymus exerts endocrine
functions, the significance of which is not yet fully appreciated. A large body of evidence attests for the existence of a
complex neuroendocrine control of thymus physiology. Long standing observations indicate that the thymus becomes
involuted during the stress response. During stress or more forcefully, during APR, the HPA axis is activated. This
results in the suppression of the T-cell-dependent adaptive immune
response, which is supported further by the suppression of the hormones
that are essential for the maintenance of the thymus and of T lymphocytes
(e.g., PRL, GH, IGF-I). Catecholamines and glucocorticoids, which are
released in large quantities during APR, induce apoptosis in the thymus
with a striking efficiency.The
elevated level of TNF" and zinc deficiency, that
develop during APR, also contribute to thymic involution and to the
suppression of the adaptive immune system
(Figure 1) [9].
Cytokine-induced hyperlipoproteinemia, clinically termed the 'lipemia
of sepsis', represents an innate, non-adaptive host immune response to
infection. Triglyceride (TG)-rich lipoproteins (VLDL and chylomicrons, CM)
bind and neutralize LPS. CM-bound LPS attenuates the hepatocellular
response to pro-inflammatory cytokines. Primary rodent hepatocytes
pretreated with CM-LPS complexes for 2 h demonstrated a near 70% reduction
in cytokine-induced NO. The lipemia of sepsis likely represents a
mechanism by which the host combats sporadic, non-life-threatening
episodes of endotoxemia. Also, it may indicate a negative regulatory
mechanism for the hepatic response to sepsis, serving to effectively
down-regulate the acute phase response [121 ].
The multiple organ failure induced by critical illness was
suggested to be a primarily functional, rather than structural,
abnormality with a potentially protective mechanism. The decline in organ function is triggered by a decrease in
mitochondrial activity and in oxidative phosphorylation, leading to
reduced cellular metabolism. This might be the consequence of acute-phase
changes in hormones and inflammatory mediators [122].
|